THE RUTI VACCINE / Our solution
Archivel Farma's proposal consists of a shorter course of antibiotic treatment (only one month compared to the current nine), along with
RUTI ® vaccination.


The RUT I® is a new polyantigenic vaccine for the treatment of Latent Tuberculosis Infection. It is produced from Mycobacterium tuberculosis fragmented into tiny particles and detoxified in order to eliminate the toxic substances produced by the bacillus. The RUTI ® vaccine is the result of the partnership between the Badalona-based Institut d’Investigació en Cičncies de la Salut Germans Trias i Pujol Foundation and Archivel Farma.